SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-002331
Filing Date
2019-11-14
Accepted
2019-11-14 15:45:10
Documents
6
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K correvio6k.htm 6-K 18197
2 MANAGEMENT'S DISCUSSION AND ANALYSIS ex991.htm EX-99.1 174722
3 CONSOLIDATED FINANCIAL STATEMENTS ex992.htm EX-99.2 453397
4 MATERIAL CHANGE REPORT DATED NOVEMBER 14, 2019 ex993.htm EX-99.3 134918
5 CERTIFICATE OF FILING - CEO ex994.htm EX-99.4 10161
6 CERTIFICATE OF FILING - CFO ex995.htm EX-99.5 9836
  Complete submission text file 0001279569-19-002331.txt   802450
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 191219638
SIC: 2834 Pharmaceutical Preparations